In summary, we have characterized the differential expression of CD18 and CD36 in neutrophils from two relevant anatomical compartments: the tumor microenvironment and TDLNs, and we have identified an association between the expression of these markers on neutrophils and the presence of metastasis in OSCC patients. Here, ITGB2 is linked to neoplasm.